Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: A comparative analysis of nine scoring methods

References

• Seeff LB, Hoofnagle JH. National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002. Hepatology 2002;36:S3–20.
   PubMedGoogle Scholar
• Wilson LE, Torbenson M, Astemborski J, Faruki H, Spooler C, Rai R, Progression of liver fibrosis among injection drug users with chronic hepatitis C. Hepatology 2006;43:788–95.
   PubMedGoogle Scholar
• Kleiner DE. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. Semin Liver Dis 2005;25:52–64.
   PubMedGoogle Scholar
• Cadranel JF, Ruffat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000;32:477–81.
   PubMed Web of Science ®Google Scholar
• Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15–20.
   PubMed Web of Science ®Google Scholar
• Dienstag JL, McHutchison JG. American Gastroenterological Association medical position statement on the management of hepatitis C. Gastroenterology 2006;130:225–30.
   PubMed Web of Science ®Google Scholar
• Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127:1704–13.
   PubMed Web of Science ®Google Scholar
• Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997;92:1302–4.
   PubMed Web of Science ®Google Scholar
• Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR cooperative study groups. J Viral Hepatol 1997;4:199–208.
   PubMed Web of Science ®Google Scholar
• Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518–26.
   PubMed Web of Science ®Google Scholar
• Forns X, Ampurdanes S, Llovet JM, Aponthe J, Quinto L, Martinez-Bauer E, Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986–92.
   PubMed Web of Science ®Google Scholar
• Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort. Hepatology 2005;42:282–92.
   PubMed Web of Science ®Google Scholar
• Westin J, Ydreborg M, Islam S, Alsiö A, Dhillon AP, Pawlotsky JM, A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection. Scand J Gastroenterol 2008;43:73–80.
   PubMed Web of Science ®Google Scholar
• Cross TJ, Rizzi P, Berry PA, Bruce M, Portman B, Harrison PM, King’s score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2009;21:730–8.
   PubMed Web of Science ®Google Scholar
• Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317–25.
   PubMed Web of Science ®Google Scholar
• Paggi S, Colli A, Fraquelli M, Vigano M, del Poggio P, Facciotto C, A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validation. J Hepatol 2008;49:564–71.
   PubMedGoogle Scholar
• Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transients elastography. J Hepatol 2008;48:835–47.
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Ong M-F, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–74.
   PubMed Web of Science ®Google Scholar
• Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;5:431–5.
   Web of Science ®Google Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri WA, Bacon BR. NASH: a proposal for grading and staging the histologic lesions. Am J Gastroenterol 1999;116:1413–9.
   Google Scholar
• Ortega L, Ladero JM, Carreras MP, Alvarez T, Taxonera C, Oliván MP, A computer-assisted morphometric quantitative analisis of iron overload in liver biopsies. A comparison with histological and biochemical methods. Pathol Res Pract 2005;201:673–7.
   PubMedGoogle Scholar
• Poynard T, Muntenau M, Morra R, Ngo Y, Imbert-Bismut F, Thabut D, Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroenterol Clin Biol 2008;32:8–21.
   PubMedGoogle Scholar
• Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239–44.
   PubMed Web of Science ®Google Scholar
• Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004;24:89–97.
   PubMed Web of Science ®Google Scholar
• Schiano TD, Azeem S, Bodian CA, Bodenheimer HC Jr, Merati S, Thung SN, Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2005;3:930–5.
   PubMedGoogle Scholar
• Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007;53:1615–22.
   PubMed Web of Science ®Google Scholar
• Shaheen AAM, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelect ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007;46:912–21.
   PubMed Web of Science ®Google Scholar
• Iacobellis A, Mangia A, Leandro G, Clemente R, Festa V, Attino V, External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis. Am J Gastroenterol 2005;100:868–73.
   PubMedGoogle Scholar
• Romero M, Ramirez M, Otero MA, Vallejo M, Corpas R, Castellano-Megias VM, Estudio comparativo de dos modelos que utilizan parámetros bioquímicos en el diagnóstico no invasivo de fibrosis hepática en pacientes con hepatitis C. Med Clin 2005;124:761–4.
   PubMedGoogle Scholar
• Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007;46:775–82.
   PubMed Web of Science ®Google Scholar
• Cheung RC, Carrie S, Shen H, Bini EJ, Ho SB, Anand BS, Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol 2008;42:827–34.
   PubMed Web of Science ®Google Scholar
• Portilla J, López-Burgos A, Saiz-de-la-Hoya-Zamácola P, Sánchez-Payá J, Bedía-Collantes M, Farazo-Atienzar I, Utilidad de dos modelos bioquímicos predictivos del grado de fibrosis hepática en la población penitenciaria con hepatitis C. Gastroenterol Hepatol 2009;32:387–94.
   PubMedGoogle Scholar
• Metwally MA, Zein CO, Zein NN. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 2004;99:286–91.
   PubMed Web of Science ®Google Scholar
• Ladero JM, López-Alonso G, Devesa MJ, Cuenca F, Ortega L, Agreda M, Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C. Rev Esp Enferm Dig 2009;101:31–6.
   PubMedGoogle Scholar
• Ferrara F, Ventura P, Vegetti A, Guido M, Abbati G, Corradini E, Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C. Am J Gastroenterol 2009;104:615–6.
   Google Scholar
• Macías J, Girón-González JA, González-Serrano M, Merino D, Cano P, Mira JA, Prediction of liver fibrosis in human immunodeficiency/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 2006;55:409–14.
   PubMed Web of Science ®Google Scholar
• Salueña I, Ladero JM, Ortega L, Devesa ML, López-Alonso G, Taxonera C, Utilidad de la biopsia hepática en el diagnóstico etiológico de las alteraciones de la analítica hepática de causa incierta. Gastroenterol Hepatol 2007;30:325–30.
   PubMedGoogle Scholar
• Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage on chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358–64.
   PubMed Web of Science ®Google Scholar
• Jhaveri R, McHutchison J, Patel K, Qiang G, Diehl AM. Specific polymorphisms in HCV genotype 3 core protein associated with intracellular lipid accumulation. J Infect Dis 2008;197:283–91.
   PubMed Web of Science ®Google Scholar